Dr. Agarwal's Health Care Ltd.

As of March 31, 2026, Dr. Agarwal's Health Care Ltd. carries a market capitalization of 128.80B, placing it among publicly traded companies globally. Its enterprise value stands at 137.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Dr. Agarwal's Health Care Ltd.'s next confirmed earnings release is scheduled for October 29, 2026.

As of March 31, 2026, Dr. Agarwal's Health Care Ltd. has 316.81M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Dr. Agarwal's Health Care Ltd. maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026. Inventory turnover of 8.63 indicates how many times Dr. Agarwal's Health Care Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Dr. Agarwal's Health Care Ltd. recorded 633.30M in income tax expense.

As of the close on October 23, 2026, Dr. Agarwal's Health Care Ltd.'s stock has declined approximately 12.58% over the past 52 weeks. The 50-day moving average sits at 495.11, while the 200-day moving average is 470.30.

These figures cover the twelve months ended March 31, 2026.

As of March 31, 2026, Dr. Agarwal's Health Care Ltd. holds 2.84B in cash and equivalents against 10.66B in total debt, resulting in a net debt position of 667.20M. Total book value stands at 20.25B, with working capital of 1.11B providing operational flexibility.